Related Experiment Video
Updated: Aug 18, 2026

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
Bioadhesive peptides as potential anticancer drug carriers: activation via isopeptide deblocking by proteases
Y Yamazaki1, M Tsuruga, B Gentsch
1National Institute of Bioscience and Human Technology, Agency of Industrial Science and Technology, Ibaraki, Japan.
Background:
Bioadhesive peptides are potentially useful as anticancer drug carriers, if the bioadhesivity becomes active only at the tumor site. We propose that this function can be achieved by the prodrug strategy using proteases in tumors.
Materials And Methods:
A laminin fragment peptide, Ac-AASIKVAVSADR-NH2 (5), and its derivatives, Ac-AASIK(L) VAVSADR-NH2 (6), Ac-AASIDpm(NH2)VAVSADR-NH2 (7) and Ac-AASIDpm(L)(NH2)VAVSADR-NH2 (8), were synthesized and tested for their bioadhesive activity with 6 cancer cell lines.
Results:
The strength of the binding was in the order of 5 >> 7 > or = 8 > or = 6. The attachment of mouse whole blood cells to peptide 6-coated surface was also weaker than to 5-coated surface. The Leu isopeptide linkage in 6 was enzymatically cleaved by the cells.
Conclusion:
The present results suggest that isopeptide 6, working as a prodrug form for the bioadhesive peptide 5, could serve as an anticancer drug carrier for tumor targeting.
Related Concept Videos
Peptide Bonds
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Cell Migration through Invadopodia
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Site-Targeted Drug Delivery Systems: Polymeric Carriers

